Health Care/Hospital

2019 CSCO | CStone releases preliminary results from the Phase Ia trial of CS1003 in Chinese patients with advanced tumors

SUZHOU, China, Sept. 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today released the preliminary data from the Phase I bridging study of the Company's investigational anti-PD-1 monoclonal antibody CS1003 for the first time, in an oral presentation at the...

2019-09-21 00:26 497

CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

Not intended for US, Canada and UK-based media  * Opinion based on Phase III data showing combination lowered risk of disease progression or death by 31% and improved objective response rate compared with sunitinib[1] * Decision by the European Commission anticipated in fourth quarter of 2019...

2019-09-20 20:34 534

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019

HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2019-09-20 19:00 1580

Nestle Displays Nutrition Innovation and Scientific Research Achievements and Wins Two Awards at the 14th China Nutrition Science Congress

NANJING, China, Sept. 20, 2019 /PRNewswire/ -- Nestle actively participated in the "14th China Nutrition Science Congress & the 11th Asia Pacific Conference on Clinical Nutrition and the 2nd Global Chinese Nutrition Scientists Conference" held fromSeptember 20 to 22, 2019 in Nanjing. The Organizi...

2019-09-20 16:53 543

Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai

SHANGHAI, Sept. 20, 2019 /PRNewswire/ - Luye Medical and Cleveland Clinic today jointly presented an architectural scale model of the world's first Cleveland Clinic Connected project-the Shanghai Luye Lilan Hospital. Various leaders from the government agency ofShanghai's Minhang District and the...

2019-09-20 15:15 615

Innovent Provides Update on Two Studies of IBI301 (Rituximab Biosimilar) in the Treatment of CD20-positive Lymphoma at Annual Meeting of CSCO

SUZHOU, China, Sept. 20, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, metabolic and other major diseases, announced today that the data for tw...

2019-09-20 14:30 531

More Than 9 in 10 Surgeons Encounter a Needlestick Injury, New Global Survey Finds

LONDON, Sept. 20, 2019 /PRNewswire/ --   * 81% believe high quality gloves impact patient outcomes; * 92% agreed high quality gloves improve safety of clinicians; * Survey demonstrates importance surgeons place on high quality gloves in protecting against infection and patient safety; * F...

2019-09-20 07:00 506

2019 CSCO | CStone announces promising trial data on its anti-PD-L1 antibody in esophageal squamous cell carcinoma with an ORR of 77.8%

SUZHOU, China, Sept. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced trial data from the esophageal squamous cell carcinoma (ESCC) cohort of a Phase Ib clinical trial of the Company's investigational anti-PD-L1 antibody CS1001 in an oral pre...

2019-09-19 23:48 625

Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic Cooperation

BROOKLINE, Massachusetts, Sept. 19, 2019 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, and China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM) today announced the execution of ...

2019-09-19 23:12 761

Chipscreen Biosciences's Oringinal New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted

SHENZHEN, China, Sept. 19, 2019 /PRNewswire/ -- The new drug application (NDA) of Chiglitazar (Bilessglu®), an innovative new chemical entity (Category 1 c hemical drug) for type 2 diabetes discovered and developed by Shenzhen Chipscreen Biosciences (Stock Symbol: 688321.SH), has been accepted by ...

2019-09-19 23:02 544

WuXi Diagnostics to open its first research facility in the U.S.

ROCHESTER, Minn., Sept. 19, 2019 /PRNewswire/ -- WuXi Diagnostics announced today the plan to open its first U.S.-based research and diagnostic testing development facility inRochester, Minnesota to accelerate esoteric diagnostic product development, and bring more personalized and accurate clini...

2019-09-19 20:00 496

More than 800 pharmaceutical companies from 23 countries gathered in Taizhou, China -- the 10th China (Taizhou) International Medical Expo is about to open

NANJING, China, Sept. 19, 2019 /PRNewswire/ -- The 10th China (Taizhou) International Medical Expo, hosted by the Jiangsu Provincial People's Government and the Taizhou Municipal People's Government, is held inChina Taizhou Medical City fromSeptember 18 to 20.

2019-09-19 19:13 491

Tresiba® Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes

BARCELONA, Spain, Sept. 19, 2019 /PRNewswire/ -- According to new data from the CONCLUDE head-to-head trial, Tresiba® (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA1c, compared with insulin glargine U300 in a...

2019-09-19 18:01 611

Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO

SUZHOU, China, Sept. 19, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, metabolic and other major diseases, announced today that the results of ...

2019-09-19 16:36 648

Springer Publishing Company Moves Complete Journal Portfolio to ScholarOne

Nursing, medical, and behavioral sciences publisher will benefit from integrated peer review services from the Web of Science Group LONDON, Sept. 19, 2019 /PRNewswire/ -- The Web of Science Group, a Clarivate Analytics company, is proud to announce that Springer Publishing Company, the innovativ...

2019-09-19 15:00 2461

AXA Hack For Health, the First Health AI Hackathon in Hong Kong Now Open for Registration

HONG KONG, Sept. 19, 2019 /PRNewswire/ -- As an innovative insurer, AXA leverages Big Data and AI Technology Solutions to provide a superb experience to help their customers to live better lives. AXA aim to drive breakthrough advances in health and protection by supporting our customers in preven...

2019-09-19 14:23 636

Taiwan Medical Professionals Assisting Malaysian Patients Rediscover Their Confidence and Rediscover Life

KUALA LUMPUR, Malaysia, Sept. 19, 2019 /PRNewswire/ -- Taiwan's medical care is renowned for its high quality, advanced technology, professionalism and affordable pricing. In fact, the cost of medical treatment inTaiwan is typically one-fifth of comparable services inEurope and the US. To further...

2019-09-19 14:05 517

IDTechEx: The Future of Medical Is Wearables? (Part 2)

BOSTON, Sept. 19, 2019 /PRNewswire/ -- This is the second of a two part series exploring wearable medical devices. In part 1, IDTechEx discussed trends indicating that "the future of wearable is medical". In part 2, we explore the question in reverse, asking to what extent "the future of medical ...

2019-09-19 10:00 623

RE:WELL REBELS launches its retreats and wellness programmes

SINGAPORE, Sept. 19, 2019 /PRNewswire/ -- RE:WELL REBELS is launching its first retreat at Hotel Fort Canning,Singapore from 1 to 3 November. People don't need to travel to an obscure location just to escape the hustle and bustle of the city. Thanks to RE:WELL REBELS, serenity is now just around ...

2019-09-19 09:30 571

BookDoc, partners it's way to being Southeast Asia's Next Generation Healthcare Ecosystem is looking to raise Series A from Strategic partners

KUALA LUMPUR, Malaysia, Sept. 19, 2019 /PRNewswire/ -- BookDoc operates across the healthcare continuum connecting patients to healthcare professionals anytime, anywhere (Search & Book) with over 40,000 healthcare providers, brings healthcare to users fingertips (Tele-Consult), incentivizes users...

2019-09-19 09:00 599
12345 ... 740